Loading...
AMBICA INTERNATIONAL CORPORATION — Cyclophosphamide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #7 buyer for Cyclophosphamide · $269.0K import value · 55 shipments · PHILIPPINES · DGFT Verified
AMBICA INTERNATIONAL CORPORATION is the #7 importer of Cyclophosphamide from India with $269.0K in import value and 55 verified shipments. AMBICA INTERNATIONAL CORPORATION holds a 1.4% market share in Cyclophosphamide imports based in PHILIPPINES. The company sources from 2 verified suppliers across 42 formulations shipped to 1 country. Overall, AMBICA INTERNATIONAL CORPORATION imports 9 pharmaceutical products worth $5.6M across 7 therapeutic categories.
Verified from 55 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GETWELL PHARMACEUTICALS | $208.0K | 44 | 77.3% |
| GETWELL PHARMA INDIA PRIVATE LIMITED | $61.0K | 11 | 22.7% |
AMBICA INTERNATIONAL CORPORATION sources Cyclophosphamide from 2 verified Indian suppliers based on 55 customs records. The primary supplier is GETWELL PHARMACEUTICALS accounting for 77.3% of imports.
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | J. KNIPPER & COMPANY | UNITED STATES | $467.5K | 14 | $33.4K |
| 3 | EUGIA US LLC, | UNITED STATES | $400.0K | 8 | $50.0K |
| 7 | AMBICA INTERNATIONAL CORPORATION ★ | PHILIPPINES | $269.0K | 55 | $4.9K |
| 5 | COMMERCIAL BANK | ETHIOPIA | $250.0K | 5 | $50.0K |
| 8 | TO THE | UNITED ARAB EMIRATES | $209.4K | 8 |
AMBICA INTERNATIONAL CORPORATION ranks #7 among 518 Cyclophosphamide importers from India. Average shipment value of $4.9K compared to the market average of $7.2K. The closest competitors by value are J. KNIPPER & COMPANY and EUGIA US LLC,.
Destination countries from 55 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $269.0K | 55 | 100.0% |
AMBICA INTERNATIONAL CORPORATION imports Cyclophosphamide to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $269.0K.
| Formulation | Value | Shipments |
|---|---|---|
| CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR IN | $19.3K | 4 |
| GLOTOXAN 500MG (CYCLOPHOSPHAMIDE FOR INJ | $10.0K | 2 |
| GLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJ | $9.9K | 2 |
| GLOTOXAN-500MG CYCLOPHOSPHAMIDE FOR INJ | $9.7K | 2 |
| CYCLIXINE- 500 MG (CYCLOPHOSPHAMIDE FOR | $9.7K | 2 |
| GLOTOXAN 500MG CYCLOPHOSPHAMIDE FOR INJECTION USP BATCH NO 3GCY03 MFG DT 01 2023 EXP DT 12 2024 | $8.9K | 1 |
| GLOTOXAN 500MG CYCLOPHOSPHAMIDE FOR INJECTION USP BATCH NO 5GCY17 MFG DT 04 2025 EXP DT 03 2027 | $8.8K | 1 |
| CYTOACE- 1 G CYCLOPHOSPHAMIDE FOR INJEC | $8.7K | 1 |
| GLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJECTION USP)BATCH NO.4GCY11, MFG.DT. 03/2024,EXP.DT 02/2026 |
India exported $3.7M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. AMBICA INTERNATIONAL CORPORATION imports $269.0K of this total, accounting for 1.4% of India's Cyclophosphamide exports with 55 shipments from PHILIPPINES. This is verified from 55 customs shipment records covering 42 distinct formulations.
AMBICA INTERNATIONAL CORPORATION's average Cyclophosphamide order value is $4.9K per consignment, based on 55 shipments totaling $269.0K. AMBICA INTERNATIONAL CORPORATION is based in PHILIPPINES and ranks #7 among all Cyclophosphamide importers from India by value. The company sources from 2 verified suppliers in India.
AMBICA INTERNATIONAL CORPORATION sources Cyclophosphamide from 2 verified Indian suppliers: GETWELL PHARMACEUTICALS ($208.0K, 77.3%), GETWELL PHARMA INDIA PRIVATE LIMITED ($61.0K, 22.7%). This is based on 55 customs records.
AMBICA INTERNATIONAL CORPORATION ranks #7 among 518 Cyclophosphamide importers from India with a 1.4% market share. The top 3 importers are EUGIA US LLC ($550.0K), CIPLA USA INC UPS SUPPLY CHAIN SOLU ($500.0K), J. KNIPPER & COMPANY ($467.5K). AMBICA INTERNATIONAL CORPORATION processed 55 shipments from PHILIPPINES.
AMBICA INTERNATIONAL CORPORATION imports 9 products worth $5.6M. Beyond Cyclophosphamide, top products include Immunoglobulin, Pioglitazone, Natural, Colchicine, Folic. View the complete AMBICA INTERNATIONAL CORPORATION profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for AMBICA INTERNATIONAL CORPORATION's Cyclophosphamide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AMBICA INTERNATIONAL CORPORATION
Full Company Profile →
9 products · $5.6M total trade · 7 categories
| $26.2K |
| $8.6K |
| 1 |
| CYTOACE 1 G (CYCLOPHOSPHAMIDE FOR INJECTION USP) BATCH NO. 4GCY15, MFG.DT. 06/2024, EXP.DT. 05/2026 | $8.5K | 1 |
AMBICA INTERNATIONAL CORPORATION imports 42 distinct Cyclophosphamide formulations from India. The top formulation is CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR IN with 4 shipments worth $19.3K.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for AMBICA INTERNATIONAL CORPORATION.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current order-level data, contact TransData Nexus.